Incyte target price cut to $150 from $154 by Leerink Partners
INCY•Leerink Partners cut its target price on Incyte to $150 from $154.
Related News
Leerink Partners cuts Ideaya Biosciences target price to $30 from $31
IDYA•
Fiserv: JPMorgan raises target price to $65 from $60
FISV•
Gartner: Jefferies raises target price to $197 from $190
IT•
Booking Holdings: RBC cuts target price to $205 from $220
BKNG•
Ideaya Biosciences, Inc.: Guggenheim cuts target price to $52 from $57
IDYA•